Who is eligible for the '100 Billion Yen Roadmap Diagnosis'?

SMEs with around ¥1B revenue facing growth stagnation or founder dependency are eligible.

Is the diagnosis really free?

Yes, completely free. Register for 'Founder's Stand-in' and complete the diagnosis and consultation.

What will I learn from the diagnosis?

You'll identify growth bottlenecks, current stage, gaps to ¥10B companies, and priority actions.

What is the 'From ¥1B to ¥10B Roadmap' strategy guide?

A free guide outlining organizational scaling, leadership development, and profitability improvement.

What is the process to use this service?

1. Register → 2. Take diagnosis → 3. Attend feedback session → 4. Receive roadmap. All free.

New Service Launch: '100 Billion Yen Company Roadmap Diagnosis' Visualizes Business Growth Stages, Analyzes Challenges from ¥1B to ¥10B Revenue, and Clarifies Next Growth Strategy

Published Jun 19, 2026 10:00 PM ・ Updated Jun 19, 2026 4:25 PM ・ 16 min read ・ Source: PR TIMES

Lumission Inc. launches a new service, the '100 Billion Yen Company Roadmap Diagnosis,' on June 22, 2026, offering it free of charge to growing SMEs aiming to scale from ¥1 billion to ¥10 billion in annual revenue. The service comprehensively analyzes product design, organization, and profitability to clarify the next growth steps.

Lumission Inc. (headquartered in Minato-ku, Tokyo) will begin offering a new diagnostic service, the '100 Billion Yen Company Roadmap Diagnosis,' starting Monday, June 22, 2026, for executives of small and medium-sized enterprises (SMEs) and growing companies targeting annual revenues from ¥1 billion to ¥10 billion.

This service is a diagnostic tool that comprehensively analyzes product design, customer acquisition, sales structure, organization, recruitment, delegation of authority, profit structure, new business development, and management strategy. It helps clarify management challenges such as 'growth has stalled around ¥1 billion in sales,' 'unable to move beyond founder dependency,' 'the organization isn't scaling,' or 'uncertain about where to invest next.'

The diagnosis analyzes each company's growth stage and visualizes the key management challenges and improvement themes that should be prioritized to reach the ¥10 billion revenue mark.

Additionally, participants in the diagnosis will receive a free strategic planning document titled 'From ¥1 Billion to ¥10 Billion Roadmap.'

Background of Service Development

Many companies face different management challenges as they grow from ¥100 million to ¥300 million, and then to ¥1 billion in annual revenue. Particularly around the ¥1 billion mark, issues previously resolved through the founder’s judgment or on-site responses reach their limits. At this stage, more advanced management design becomes essential—such as organizational scaling, executive development, delegation of authority, profit management, and new business development.

However, in practice, many companies struggle to objectively identify where their growth is stalling. Complex, interrelated issues—such as inability to escape founder dependency, stagnant productivity despite organizational growth, declining profit margins, and failure to develop capable executives—often obscure the root causes.

We believe the core issue is not isolated problems, but the lack of a structured management framework to transition into the next growth stage.

Therefore, we have developed this new service, the '100 Billion Yen Company Roadmap Diagnosis,' to visualize a company’s growth phase and clarify the management priorities and improvement themes necessary to reach ¥10 billion in revenue.

What is the '100 Billion Yen Company Roadmap Diagnosis'?

This service is a diagnostic program that analyzes the key elements required for business growth from multiple angles. The diagnosis comprehensively evaluates:

- Product design

- Customer acquisition structure

- Sales structure

- Profit structure

- Organizational structure

- Recruitment capability

- Executive development

- Delegation of authority

- New business development

- Management strategy

Based on the diagnosis results, the following will become clear:

- Bottlenecks hindering growth

- Current growth stage

- Gaps compared to ¥10 billion companies

- Management issues that should be prioritized

- Next actions to take

Free 'From ¥1 Billion to ¥10 Billion Roadmap' for Diagnosis Participants

Participants in this diagnosis will receive the 'From ¥1 Billion to ¥10 Billion Roadmap' free of charge.

This document outlines:

- Steps to grow from ¥1 billion to ¥10 billion in revenue

- Challenges during organizational scaling phases

- Approaches to executive development

- Design of authority delegation

- Profit structure improvement

- New business design

- Prioritization of growth investments

What You’ll Learn from the Diagnosis

- The real reasons growth has stalled

- Conditions necessary to become a ¥10 billion company

- Why founder dependency occurs

- Why the organization isn’t scaling

- Why profit margins are declining

- The truly critical growth themes to prioritize

Business growth doesn’t depend on effort or perseverance alone—it fundamentally changes based on 'design at each growth stage.'

Why Is This Offered for Free?

Lumission Inc. emphasizes sustainable business design that enables long-term growth, rather than merely supporting short-term sales increases.

Our advocated 'Five-Way Win Management' philosophy aims to simultaneously achieve benefits for:

- The company

- Employees

- Customers

- Society

- Future generations

As the first step toward this vision, we are offering this diagnosis free of charge to provide companies with an opportunity to reflect on and organize their growth challenges.

What Is 'The Founder's Stand-in'?

'The Founder's Stand-in' is a free consultation service for executives provided by Lumission Inc.

It allows unlimited free consultations on any management challenges, including sales, profits, organization, recruitment, customer acquisition, and business strategy.

The '100 Billion Yen Company Roadmap Diagnosis' is being offered as an exclusive benefit for registered members of 'The Founder's Stand-in.' Participants can receive individual feedback based on their diagnosis results, helping them organize management challenges and clarify future growth strategies.

Service Process

1. Free registration for 'The Founder's Stand-in' (30 seconds)

2. Complete the 100 Billion Yen Company Roadmap Diagnosis (free)

3. Attend an individual feedback session (free)

4. Receive the 'From ¥1 Billion to ¥10 Billion Roadmap'

▶ Register for the free diagnosis here: https://lp.lumission.world/

* This offer is available on a first-come, first-served basis and may end once the capacity is reached.

Future Developments

Lumission Inc. will continue to accumulate data on management challenges tailored to different business growth stages through the '100 Billion Yen Company Roadmap Diagnosis.' In the future, based on diagnosis results, we plan to analyze common challenges and success factors among growing companies and develop industry-specific and stage-specific diagnostic content and management reports.

Additionally, we aim to evolve into an integrated support program combining organizational design, recruitment design, and business strategy design, providing long-term support for companies aiming to grow from ¥1 billion to ¥10 billion in revenue.

We will continue striving to realize a sustainable management environment based on the 'Five-Way Win Management' philosophy.

Company Overview

Company Name: Lumission Inc.

Headquarters: 7F, Shinagawa East One Tower, 2-16-1 Konan, Minato-ku, Tokyo

Business: Management support and consulting for SMEs

Official Website: https://lumission.world/jp/

FACT BOX

Source: PR TIMES
Category: New Product

New Service Launch: '100 Billion Yen Company Roadmap Diagnosis' Visualizes Business Growth Stages, Analyzes Challenges from ¥1B to ¥10B Revenue, and Clarifies Next Growth Strategy

⚡ Key Points